Author :   Karaman О.М.*

Oxamate, an inhibitor of lactate dehydrogenase, can stimulate M2 polarization of peritoneal macrophages in mice with Lewis lung carcinoma
Authors :Solyanik G.I. Karaman О.М.* Yakshibaeva Y.R. Pyaskovskaya O.N.... Date: 2021-09-30 / Views: 184
Macrophages — a perspective target for antineoplastic immunotherapy
Authors :Karaman О.М.* Ivanchenko A.V. Chekhun V.F. Date: 2019-12-04 / Views: 358
2537_330The effects of early postoperative immunization with xenogeneic embryo proteins on Lewis lung carcinoma model
Authors :Symchych T.V.* Fedosova N.I. Karaman О.М.* Voyeykova I.M.... Date: 2018-12-28 / Views: 285
2349_01Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma
Authors :Symchych T.V.* Fedosova N.I. Karaman О.М.* Yevstratieva L.M.... Vol. 39, No. 1 / Views: 345
Effect of enterosorption on paraneoplastic syndrome manifestations in mice with highly angiogenic variant of lewis lung carcinomaEffect of enterosorption on paraneoplastic syndrome manifestations in mice with highly angiogenic variant of lewis lung carcinoma
Authors :Sarnatskaya V.V. Nikolaev V.G. Yushko L.A. Paziuk L.M.... Vol. 37, No. 4 / Views: 309
Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules
Authors :Symchych T.V.* Fedosova N.I. Karaman О.М.* Yevstratieva L.M.... Vol. 37, No. 3 / Views: 235
Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16
Authors :Fedosova N.I. Voeykova I.M. Karaman О.М.* Symchych T.V.*... Vol. 37, No. 2 / Views: 292
The anticancer efficiency of the xenogeneic vaccine and the indication for its useThe anticancer efficiency of the xenogeneic vaccine and the indication for its use
Authors :Symchych T.V.* Fedosova N.I. Karaman О.М.* Yevstratieva L.M.... Vol. 36, No. 2 / Views: 263
Use of xenogeneic vaccine modified with embryonal nervous tissue antigens in the treatment of B16‑melanoma-bearing miceUse of xenogeneic vaccine modified with embryonal nervous tissue antigens in the treatment of B16‑melanoma-bearing mice
Authors :Voeykova I.M. Fedosova N.I. Karaman О.М.* Yudina O.Y.... Vol. 36, No. 1 / Views: 303